MetaVia Inc reports results for the quarter ended June 30 - Earnings Summary
MetaVia Inc reports results for the quarter ended June 30 - Earnings Summary
MetaVia Inc MTVA.OQ reported a quarterly adjusted loss of 90 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.86. The mean expectation of three analysts for the quarter was for a loss of 82 cents per share. Wall Street expected results to range from -87 cents to -76 cents per share.
Reported revenue was zero; analysts expected zero.
MetaVia Inc's reported EPS for the quarter was a loss of 90 cents.
The company reported a quarterly loss of $5.32 million.
MetaVia Inc shares had risen by 4.2% this quarter and lost 82.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.8% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for MetaVia Inc is $20.00, about 92.6% above its last closing price of $1.49
This summary was machine generated from LSEG data August 6 at 10:11 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.82 | -0.90 | Missed |
Mar. 31 2026 | -0.74 | -0.79 | Missed |
Dec. 31 2025 | -1.24 | -0.42 | Beat |
Sep. 30 2025 | -2.44 | -1.54 | Beat |
Recent news on MetaVia
See all newsMetaVia Inc reports results for the quarter ended June 30 - Earnings Summary
MetaVia Q2 net loss widens on higher R&D spending
MetaVia Inc expected to post a loss of 82 cents a share - Earnings Preview
Brief: Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors
MetaVia Q1 net loss widens slightly as expenses rise